Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer. | Front Oncol | 2019 | 31921637 | PubTator, text mining | PubMed |
| Curcumin Regulates the Progression of Colorectal Cancer via LncRNA NBR2/AMPK Pathway. | Technol Cancer Res Treat | 2019 | 31888414 | PubTator, text mining | PubMed |
| Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma. | Sci Rep | 2019 | 31882684 | PubTator, text mining | PubMed |
| Model-based cell clustering and population tracking for time-series flow cytometry data. | BMC Bioinformatics | 2019 | 31881827 | PubTator, text mining | PubMed |
| Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 Inhibitor. | Biomolecules | 2019 | 31878201 | PubTator, text mining | PubMed |
| Intracellular calcium signaling and phospho-antigen measurements reveal functional proximal TCR activation in lymphocytes from septic shock patients. | Intensive Care Med Exp | 2019 | 31873820 | PubTator, text mining | PubMed |
| Regulation and Role of GLI1 in Cutaneous Squamous Cell Carcinoma Pathogenesis. | Front Genet | 2019 | 31867038 | PubTator, text mining | PubMed |
| Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors. | Ann Oncol | 2019 | 31859350 | PubTator, text mining | PubMed |
| Overview of the relevance of PI3K pathway in HR-positive breast cancer. | Ann Oncol | 2019 | 31859348 | PubTator, text mining | PubMed |
| Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S. | Chem Sci | 2019 | 31857889 | PubTator, text mining | PubMed |
| Hydrogen sulfide treatment alleviated ventilator-induced lung injury through regulation of autophagy and endoplasmic reticulum stress. | Int J Biol Sci | 2019 | 31853224 | PubTator, text mining | PubMed |
| A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival. | J Bone Oncol | 2019 | 31832331 | PubTator, text mining | PubMed |
| Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects. | J Exp Clin Cancer Res | 2019 | 31831021 | PubTator, text mining | PubMed |
| The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment. | Cancers (Basel) | 2019 | 31817109 | PubTator, text mining | PubMed |
| MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40. | Cell Transplant | 2019 | 31813279 | PubTator, text mining | PubMed |
| Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution. | Nat Commun | 2019 | 31811131 | PubTator, text mining | PubMed |
| Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer. | Breast Cancer Res | 2019 | 31801615 | PubTator, text mining | PubMed |
| Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53. | Commun Biol | 2019 | 31799437 | PubTator, text mining | PubMed |
| Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy. | Front Immunol | 2019 | 31787971 | PubTator, text mining | PubMed |
| The AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response. | Life Sci Alliance | 2019 | 31767615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=51